Laporan Kasus : Thymik Karsinoma dengan Efusi Perikard
Abstract
References
Brichel, AR. (2008). Thymoma. Uniformed Science University of The Health Science.Austria.Available from:
Desai, SS., Jambhekar, NA. (2004). Classification of
Thymic Neoplasms: Observation on the WHO 1999, Classification based on 5 cases,India Journal surgery. Vol.66,pp.93-6.
Duwe, B., Musani, A., Sterman, D. (2005). Tumors of the Mediastinum,Chest. Vol.128, pp.2893- 909. Available from: http://chestjournal.org.
Fisman, AP., Elias, J., Fishman,JA., et al. (2008),Disease of the Mediastinum In: Fishman’s Manual of Pulmonary Disease and Disorders.4th edition. McGraw-Hill, New York,pp.494- 500.
Fuhler, CD., Houseman, MD. (2008), Radiotherapy for Thymoma And Thymic Carcinoma,Hematology Clin. Oncol. Clin.of North America. Elsevier Saunders. San Antonio, USA. pp.489 – 507.
Giaccone, G. (2000),Treatment of Thymoma and Thymic carcinoma, Division of Medical Oncology. University Hospital Vrije
Universiteit, Amsterdams, the Netherlands. Available from:
http://www.Oxfordjournals.org/cgi/reprint/11
/suppl.
Kondo, K. (2008),Optimal Theraphy of Thymoma:Article Review, School of Health Science, University of Tokushima. Tokushima, Japan.
Loehrer, PJ., Sr Jiroutek, M., Aisner, S., et al. (2010).
Combined etoposide, Ifosfamide and cisplatine in the treatment of patients with advanced thymoma and thymic carcinoma, J
ofCancer vol.91(11), pp.2010-15.
Musani, A., Sterman, D. (2004),Tumors of the mediastinum, pleura, chest wall and diaphragm. In: Baum’s Textbook of
Pulmonary Disease. Editors: Crapo J, Glassroth J, Karlinsky, King T. 7th edition,Publish by Lippincot Williams & Wilkins,
Philadelphia. pp.883-9.
National Cancer Institute. (2010).Thymoma and Thymic carcinoma treatment. Available from:http://BMJNonaka, T., Tamaki, Y. (2004), Japan Clinical Oncology: The Role of Radiotherapy For
Thymic Carcinoma, Department Radiology Oncology, 12th Edition. JJCO Hyh,Japan.pp.722 – 66.
Ogawa, K., Toita, T., Uno, T., et al. (2002).Treatment and Prognostic of Thymic Carcinoma. In: Inter Science Cancer. American Cancer Society. 94, pp. 3115-3119.
Perhimpunan Dokter Paru Indonesia. (2003). Tumor Mediastinum: Tumor Timoma, Pedoman Diagnosis dan Penatalaksanaan di
Indonesia.pp.6-8.
Rena, O., Papalio,E. (2006). Does Adjuvant Radiotherapy Improve Disease free survival completely resected Masaoka Stage II
Thymoma? Cardio-Thoracic Surgery Department, Elsevier: European Thoracic Surg. J,Vol 31, pp.109-113.
Roberts, R., Kasier J., R, Larry.(2008). Aquired Lession Of Mediastinum:Benign and Malignant, Fishman’s Pulmonary Diseases, Mc Grawhill Company, 4th Edition. Tennessee, US,pp.1583-5.
Singhal, S., Shrager, BJ. (2003),Comparison of Stage I –II Thymoma Treated by Complete Resection With Or Without Adjuvant
Radiation, Department Of Oncology, Radiation And Pathology Laboratory Medicine, Philidelphia. Available from:
Soler, J., Sagrist-Sauleda, J., Permanyer-Miralda. (2001).Gaieta: Management of pericardial effusion.(Statistical Data Included). Strobel, P., Bauer, A. (2004). Tumor Recurrence and Survival in The Patient Treated for Thymoma and Thymic Squamous Cell Carcinoma, J of Clin. Oncol,Vol 2(8).
Venuta, F., Anile, M., Diso, D., Virolo, D., et al.(2010). Thymoma and Thymic carcinoma. European Cardiothoracic Surg. J, vol.37,pp.13-25.
William, JS.,Ramin, A., Sovari, AA., Kocheril, AG.(2010). Malignant pericardial effusions,National Cancer Institute. E-medicine cardiol.
Authors

Qanun Medika by FK UM Surabaya is liscence under Lisensi Creative Commons Atribusi 4.0 Internasional.